ASSIGNMENT AND EXCLUSIVE CROSS-LICENSE AGREEMENTAssignment and Exclusive Cross-License Agreement • November 5th, 2013 • Biocept Inc • Services-medical laboratories • California
THIS ASSIGNMENT AND EXCLUSIVE CROSS-LICENSE AGREEMENT (the “Agreement”) is entered into as of June 2, 2012 (the “Effective Date”) by and between AEGEA BIOTECHNOLOGIES, a California corporation, with an address of 15638 Boulder Mountain Road, Poway, California 92064 (“Aegea”), and BIOCEPT, INC., a Delaware corporation, with an address of 5810 Nancy Ridge Drive, San Diego, California 92121 (“Biocept”).
LEASE (Nexus/Biocept)Lease • November 5th, 2013 • Biocept Inc • Services-medical laboratories
THIS LEASE (“Lease”), dated for reference purposes only March 31, 2004, is made by and between NEXUS EQUITY VIII LLC, a California limited liability company (“Landlord”), and BIOCEPT, INC., a California corporation (“Tenant”).
COLLABORATION AGREEMENTCollaboration Agreement • November 5th, 2013 • Biocept Inc • Services-medical laboratories • California
THIS COLLABORATION AGREEMENT (the “Agreement”) is entered into as of November 2, 2012 (the “Effective Date”) by and between BIOCEPT, INC., a California corporation having an address of 5810 Nancy Ridge Drive, Suite 150, San Diego, CA 92121 (“Biocept”), and LIFE TECHNOLOGIES CORPORATION, a Delaware corporation having an address of 5791 Van Allen Way, Carlsbad, California 92008 (“Life Technologies”).
RESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • November 5th, 2013 • Biocept Inc • Services-medical laboratories • Delaware
This Restricted Stock Unit Agreement (this “Agreement”) is made and entered into as of August 8, 2013 (the “Grant Date”) by and between Biocept, Inc., a Delaware corporation (the “Company”) and [DIRECTOR NAME] (the “Grantee”).
COLLABORATION AGREEMENTCollaboration Agreement • November 5th, 2013 • Biocept Inc • Services-medical laboratories • California
THIS COLLABORATION AGREEMENT (the “Agreement”) is entered into as of August 17, 2011 (the “Effective Date”) by and between BIOCEPT, INC., a California corporation having an address of 5810 Nancy Ridge Drive, Suite 150, San Diego, CA 92121 (“Biocept”), and CLARIENT DIAGNOSTIC SERVICES, INC., a Delaware corporation having an address of 31 Columbia, Aliso Viejo, California 92656 (“Clarient”).
NOTE CONVERSION AGREEMENTNote Conversion Agreement • November 5th, 2013 • Biocept Inc • Services-medical laboratories • California
THIS NOTE CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of June 28, 2013, by and between BIOCEPT, INC., a California corporation (the “Company”), and Campbell Family Trust (the “Noteholder”).
OMNIBUS AMENDMENT AGREEMENTOmnibus Amendment Agreement • November 5th, 2013 • Biocept Inc • Services-medical laboratories • California
This OMNIBUS AMENDMENT AGREEMENT (this “Amendment”) is entered into as of September 30, 2011, by and among Biocept, Inc., a California corporation (the “Company”), and each of the entities identified on the signature pages hereto (each an “Investor” and collectively the “Investors”).
MASTER LABORATORY RESEARCH SUPPORT AND SERVICES AGREEMENTSupport and Services Agreement • November 5th, 2013 • Biocept Inc • Services-medical laboratories
This Statement of Work (“SOW”), dated and effective June 20, 2012, submitted in connection with the Master Laboratory Services Agreement by and between Biocept and Dana Farber Partners Cancer Care, Inc. dated July 9, 2012 (“Agreement”), is hereby agreed to by the Parties.
NOTE CONVERSION AGREEMENTNote Conversion Agreement • November 5th, 2013 • Biocept Inc • Services-medical laboratories • California
THIS NOTE CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of June 28, 2013, by and between BIOCEPT, INC., a California corporation (the “Company”), and Bruce E. Gerhardt (the “Noteholder”).
AMENDED AND RESTATED LOAN AGREEMENT BETWEEN GOODMAN CO. LTD. AND BIOCEPT, INC.Security Agreement • November 5th, 2013 • Biocept Inc • Services-medical laboratories • California
WHEREAS, Biocept, Inc., a California corporation (“Borrower”) and Goodman Co. Ltd. (“Lender”) are parties to that certain Amended and Restated Loan Agreement dated January 29, 2009 (the “Prior Loan Agreement”), which amended and restated that certain Amended and Restated Loan Agreement dated June 26, 2007 (the “First Amended Loan Agreement”), which amended and restated that certain Loan Agreement dated April 20, 2005;
BIOCEPT, INC. NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • November 5th, 2013 • Biocept Inc • Services-medical laboratories • California
THIS NOTE AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of February 1, 2011 (the “Effective Date”) by and among BIOCEPT, INC., a California corporation (the “Company”) and the Investors listed on the Schedule of Investors attached hereto (each an “Investor and collectively, the “Investors”).
